about
Treatment of early Parkinson's disease.Investigation by Parkinson's Disease Research Group of United Kingdom into excess mortality seen with combined levodopa and selegiline treatment in patients with early, mild Parkinson's disease: further results of randomised trial and confidential iNeuroprotective actions of selegiline.Milestones in Parkinson's disease therapeutics.Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions.Selegiline, or the problem of early termination of clinical trials. The clinical questions are not well answered, and probably never will be.Neuroprotection in Parkinson's disease: love story or mission impossible?Impact of sustained deprenyl (selegiline) in levodopa-treated Parkinson's disease: a randomized placebo-controlled extension of the deprenyl and tocopherol antioxidative therapy of parkinsonism trial.The treatment of Parkinson's disease in older people.
P2860
Q33714133-9E675BAF-8BB3-4C20-AE73-6A553FBFAB8BQ33778395-14A0CE97-0EBA-43D7-A2CD-45E7DF194F19Q34507186-2023C5E4-930A-4AC9-B963-5A8608826F22Q37882596-76F2786E-EBBB-4773-8A00-68C0EFDA55A9Q42455114-FB7A4EB2-0A6D-4AE1-9F48-EDA101256128Q42756618-930BF5EC-B5C8-43AB-B8BA-46E5393A56A8Q43265626-0E94F33E-01A1-49D7-A1ED-595F6B1734CAQ44060104-DD9ECFF3-47EA-4697-90C4-07DA82DCC8E2Q48338523-A75E31E5-3D2B-4CB0-BB10-2B45C31C3775
P2860
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Selegiline and mortality in Parkinson's disease.
@en
type
label
Selegiline and mortality in Parkinson's disease.
@en
prefLabel
Selegiline and mortality in Parkinson's disease.
@en
P2093
P2860
P356
P1433
P1476
Selegiline and mortality in Parkinson's disease.
@en
P2093
P2860
P304
P356
10.1002/ANA.410400605
P50
P577
1996-12-01T00:00:00Z